You are here

Publications

] Year

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Grevengoed TJ, Martin SA, Katunga L, Cooper DE, Anderson EJ, Murphy RC, Coleman RA. 2015. Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function. J Lipid Res. 56(8):1572-82.

Tang WHo, Stitham J, Jin Y, Liu R, Lee SHee, Du J, Atteya G, Gleim S, Spollett G, Martin K et al.. 2014. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation. 129(15):1598-609.

B

Hayer KE, Pizarro A, Lahens NF, Hogenesch JB, Grant GR. 2015. Benchmark Analysis of Algorithms for Determining and Quantifying Full-length mRNA Splice Forms from RNA-Seq Data. Bioinformatics.

Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA. 2015. Bidirectional interactions between indomethacin and the murine intestinal microbiota.. Elife. 4

Chatr-Aryamontri A, Breitkreutz B-J, Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A, Kolas N, O'Donnell L et al.. 2015. The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43(Database issue):D470-8.

Jiang Y, Djuric Z, Sen A, Ren J, Kuklev D, Waters I, Zhao L, Uhlson CL, Hong YH, Murphy RC et al.. 2014. Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila). 7(10):1011-22.

Mazaleuskaya LL, Lawson JA, Li X, Grant G, Mesaros C, Grosser T, Blair IA, Ricciotti E, FitzGerald GA. 2016. A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood. JCI Insight. 1(12)

C

Vanichakarn P, Hwa J, Stitham J. 2014. Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies. Curr Mol Med. 14(7):849-79.

Stitham J, Vanichakarn P, Ying L, Hwa J. 2014. Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs. Curr Mol Med. 14(7):909-31.

Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK et al.. 2014. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Res. 74(23):7069-78.

Yuan C, Smith WL. 2015. A Cyclooxygenase-2-dependent Prostaglandin E2 Biosynthetic System in the Golgi Apparatus. J Biol Chem. 290(9):5606-20.

D

Toung JM, Lahens N, Hogenesch JB, Grant G. 2014. Detection theory in identification of RNA-DNA sequence differences using RNA-sequencing. PLoS One. 9(11):e112040.

Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL. 2016. Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis. J Biol Chem. 291(8):4069-78.

Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T. 2014. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 111(47):16830-5.

Guo L, Worth AJ, Mesaros C, Snyder NW, Glickson JD, Blair IA. 2016. Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism. Rapid Commun Mass Spectrom. 30(16):1835-45.

Griffin JL, Wang X, Stanley E. 2015. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet. 8(1):187-91.

E

Moore JH, Hwa J. 2014. Editorial: pharmacogenetics and molecular medicine: "so close and yet so far". Curr Mol Med. 14(7):803-4.

Lu Y-C, Chang S-H, Hafner M, Li X, Tuschl T, Elemento O, Hla T. 2014. ELAVL1 Modulates Transcriptome-wide miRNA Binding in Murine Macrophages. Cell Rep. 9(6):2330-43.

Chang S-H, Elemento O, Zhang J, Zhuang ZW, Simons M, Hla T. 2014. ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis. Proc Natl Acad Sci U S A. 111(51):18309-14.

Proia RL, Hla T. 2015. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest. 125(4):1379-87.

Li X, Ballantyne LL, Che X, Mewburn JD, Kang JX, Barkley RM, Murphy RC, Yu Y, Funk CD. 2015. Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice. J Am Heart Assoc. 4(4)

F

Goya J, Wong AK, Yao V, Krishnan A, Homilius M, Troyanskaya OG. 2015. FNTM: a server for predicting functional networks of tissues in mouse. Nucleic Acids Res. 43(W1):W182-7.

Keramati AR, Fathzadeh M, Go G-W, Singh R, Choi M, Faramarzi S, Mane S, Kasaei M, Sarajzadeh-Fard K, Hwa J et al.. 2014. A form of the metabolic syndrome associated with mutations in DYRK1B. N Engl J Med. 370(20):1909-19.

G

Prilutsky D, Kho AT, Palmer NP, Bhakar AL, Smedemark-Margulies N, Kong SWon, Margulies DM, Bear MF, Kohane IS. 2015. Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures.. Mol Autism. 6:66.

H

Fitzgerald DJ, FitzGerald GA. 2013. Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circ Res. 112(1):174-94.

Pages